6-KThe Wire
HUTCHMED (China) Ltd files 6-K
Filed Apr 9, 2026 · 2mo ago · Accession 0001648257-26-000024
Plain English
Hutchmed (China) Limited announced that data from its oncology drug candidate, savolitinib, will be presented at the AACR Annual Meeting 2026. This filing does not contain financial results.
Filing details
- Company
- HUTCHMED (China) Ltd
- Ticker
- HCM
- CIK
- 1648257
- Form type
- 6-K
- Filing date
- Apr 9, 2026
- Report date
- Apr 9, 2026
- Document
- hcm-20260409x6k.htm
- Size
- 58 KB